Clinical Trials Directory

Trials / Terminated

TerminatedNCT04504682

Ambulation With Labor Epidural in Obese Women

Neuraxial Analgesia With and Without Ambulation in Laboring Nulliparous Obese Women

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if ambulation with a labor epidural in place is associated with decreased rate of cesarean delivery in obese patients.

Detailed description

Obese women are known to have increased risk of cesarean delivery and prolonged labors. Low concentration epidural analgesia can achieve pain relief and allow for ambulation. Prior investigations have not shown a benefit in cesarean delivery between those who ambulate with an epidural and those who do not. These studies were conducted in women with normal weights. It is unknown if ambulation with a labor epidural is beneficial in decreasing cesarean delivery among obese women. Obese women at term with a singleton pregnancy will be enrolled in this pilot study. Patients will receive their epidural analgesia when they desire per standard protocol at our institution. Following epidural placement, a Modified Bromage Score and straight leg test will be performed. If the patient passes the straight leg test and has a modified Bromage score \> 6, they will be allowed to ambulate. They will be encouraged to ambulate for 20 minutes per hour with another adult alongside them. Obstetric care will be standard of care. On postpartum day one, the patient will be administered a Labor Agentry Scale. Chart review will then be conducted to review maternal and neonatal outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAmbulationPatients will be encouraged to ambulate for 20 minutes of every hour.

Timeline

Start date
2020-08-25
Primary completion
2022-05-31
Completion
2022-05-31
First posted
2020-08-07
Last updated
2023-05-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04504682. Inclusion in this directory is not an endorsement.